Fundraising Fox

제너럴바이오

1 known investors

Korean bio manufacturer of health functional foods, cosmeceutical cosmetics and eco-friendly household products, certified as a social enterprise.

Also known as GB · General Bio Co., Ltd. · 제너럴바이오(주) · 제너럴바이오㈜

Investors · 1

Company profile

researched Aug 2026

제너럴바이오(주) (General Bio) is a Korean manufacturer of health functional foods, cosmeceutical cosmetics, weight-management/diet foods and household products, operating from Namwon in Jeollabuk-do province. Its business lines span bio-cosmetics, eco-friendly cleaning agents, ginseng and health functional foods, bio raw materials, surface polishes and indoor fragrances, LED and electrical diagnostic/therapeutic devices. In the food category, omega-3, inner-beauty and complex amino acid products are described as core lines.

The company positions itself around research in bio-convergence, nanotechnology, polymer technology and bio new materials, and states it holds multiple patents on new-material and new-technology work. Materials it cites include ALA (5-aminolevulinic acid) and MAL (methyl aminolevulinate acid), both registered in the International Cosmetic Ingredient Dictionary (ICID), the ginseng saponins Compound K and Rg2 used in bio foods and cosmetics, and rice fermentation extract and rice bran oil used in eco-friendly cleansers.

A stated corporate framework, "GB WAY," defines the company's mission as job creation for socially disadvantaged groups and development of raw materials and products beneficial to people, with a vision of becoming a global social enterprise, guided by four behavioral principles of respect, positivity, communication and consideration. The corporate group presentation also covers affiliated entities GCOOP and GCOOPER TRUST.

Business model

The company develops and manufactures finished consumer goods — cosmetics, health functional foods, diet foods and household/cleaning products — alongside bio raw materials and new-material research, and presents affiliated group entities GCOOP and GCOOPER TRUST in its corporate structure. Reported revenue was KRW 4.82bn in FY2025, down from KRW 8.60bn in FY2024 and KRW 11.66bn in FY2023, with operating losses in each of those years.

Traction

Reported FY2025 revenue of KRW 4.82bn (down 44% year on year), FY2025 operating loss of KRW 6.11bn and net loss of KRW 9.81bn; total assets of KRW 29.24bn at end-2025. Headcount of 83 as of 2026. First export shipment of a functional omega-3 product to Malaysia in 2025, valued at about USD 38,000 (approximately KRW 53m).

Latest developments

In 2025 the company completed a joint technology development project supported by the Ministry of Agriculture, Food and Rural Affairs and executed by the Korea Food Industry Cluster Promotion Agency, standardizing its soft-capsule production process and registering its omega-3 product with Malaysia's food and drug authority. An export commemoration shipping ceremony was held on 2 September 2025 for the Malaysia shipment. Board notices on the company site include a record-date and shareholder-register closure announcement for an extraordinary general meeting.

Full profile — market position, technology, go-to-market, geography, history, risks & controversies

Market position

Listed 36th by disclosed revenue among peers in the Korean household chemicals/cosmetics industry classification on a jobs-data platform (2025 basis), classified as a small or medium-sized enterprise. Holds Korean social enterprise certification and U.S. B Corp certification.

Technology

Research and development focused on bio-convergence, nanotechnology, polymer technology and bio new materials. Named materials include ALA (5-aminolevulinic acid) and MAL (methyl aminolevulinate acid), registered in the ICID cosmetic ingredient dictionary, ginseng saponins Compound K and Rg2, and rice fermentation extract and rice bran oil for eco-friendly cleansers. In 2025 the Korea Food Industry Cluster Promotion Agency provided process engineering support that refined raw-material dissolution temperature, forming/filling temperature and drying speed for soft-capsule production, addressing film tearing and surface non-uniformity and reducing defect rates.

Go-to-market

Consumers of cosmetics, health functional foods, diet foods and household products; the company also describes overseas market entry, with an initial export to Malaysia.

Geography

Headquarters and plant in Namwon, Jeollabuk-do, South Korea (254 Yongtusan-ro, Songdong-myeon), with a second plant established at the Jeonbuk Technopark R&D center. Export activity includes registration of an omega-3 product with Malaysia's drug regulator and a first shipment to Malaysia in 2025.

History

The company was established in 2007 (recorded as 2007-10-25 and 2007-11 in different corporate registries) and accumulated a series of Korean government certifications: venture business certification (2009), corporate R&D center recognition (2010-07), Jeollabuk-do promising SME designation (2010-12), Inno-Biz technology-innovation SME certification and ISO 9001/14001 (2011), social enterprise certification (2011-07), a second plant at the Jeonbuk Technopark R&D center (2012-12), Main-Biz management-innovation SME certification (2013-07), Ministry of Employment and Labor "strong small enterprise" selection and a Presidential commendation for contributions to fostering social enterprises (2014), standard workplace for the disabled certification (2014-09), and U.S. B Corp certification (2015-03). A Namwon campus was recorded in 2015. Jeong Seok-geun was announced as new CEO in June 2021; Seo Jeong-hoon is listed as the representative in 2025-2026 records.

Risks & controversies

Financial disclosures show revenue declining for four consecutive reported years (KRW 24.07bn in 2022 to KRW 4.82bn in 2025) and operating losses in 2023, 2024 and 2025, with a FY2025 net loss of KRW 9.81bn and total assets falling about 25% year on year. Third-party industry scoring places the company in the lowest bands for activity, profitability and growth, while rating stability highest on the basis of a 91.8% equity ratio.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
EmployeesJan 202683 people
Equity ratioDec 202591.8%
First export shipment valueSep 2025$38K
Net incomeDec 2025−$9.8B
Operating incomeDec 2025−$6.1B
Paid in capitalDec 2025$2.8B
RevenueDec 2025$4.8B
Total assetsDec 202529,235,908,000 KRW

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 16

launches, deals, and filings
Aug 2026
Record date and shareholder register closure set for extraordinary general meeting

Public notice setting the record date and shareholder-register closure period for convening an extraordinary general meeting of shareholders; similar notices were posted in 2024 and 2021.

source ↗

Sep 2025
First omega-3 export shipment to Malaysia

Held an export commemoration shipping ceremony for a functional omega-3 product bound for Malaysia, with shipment volume worth about USD 38,000 (approx. KRW 53m), following registration of the product with Malaysia's food and drug authority.

$38K source ↗

Jan 2025
Joint technology development project with Korea Food Industry Cluster Promotion Agency

Participated in the 2025 Joint Technology Development Project funded by the Ministry of Agriculture, Food and Rural Affairs and executed by the Korea Food Industry Cluster Promotion Agency, receiving on-site technical support that standardized soft-capsule production conditions and lowered defect rates.

source ↗

Jun 2021
Jeong Seok-geun appointed CEO

Company notice announcing the inauguration of Jeong Seok-geun as new representative director.

source ↗

Mar 2015
U.S. B Corp certification

source ↗

Sep 2014
Standard workplace for the disabled certification

source ↗

Jul 2014
Presidential commendation for contribution to fostering social enterprises

source ↗

Jan 2014
Selected as a 'strong small enterprise' by the Ministry of Employment and Labor

source ↗

Jul 2013
Main-Biz management innovation SME certification

source ↗

Dec 2012
Second plant established at Jeonbuk Technopark R&D center

source ↗

Nov 2012
Venture Grand Prize, commendation from the Administrator of the Small and Medium Business Administration

source ↗

Jul 2011
Social enterprise certification

source ↗

Jun 2011
Inno-Biz technology innovation SME certification

source ↗

Jul 2010
Corporate R&D center recognition

source ↗

Jan 2009
Venture business certification

Recorded as 2009-09 in one registry and 2009-10 in another.

source ↗

Oct 2007
Company established

Founding date recorded as 25 October 2007 in one corporate registry and as November 2007 in another.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does 제너럴바이오 do?
Korean bio manufacturer of health functional foods, cosmeceutical cosmetics and eco-friendly household products, certified as a social enterprise.
Who are 제너럴바이오's investors?
제너럴바이오's investors include Laguna Investment.